Broadcast Night with CHES, Novo Nordisk & Dr. Shevta Gupta
Wednesday, February 26 at 7:00 - 8:00 PM ET
In partnership with Novo Nordisk, we are excited to host a virtual presentation on Wednesday, February 26, 2025, at 7:00 PM – 8:00 PM ET to learn about a new subcutaneous prophylaxis option in a prefilled injection pen for adults and adolescents who have hemophilia B or A with inhibitors! Our speaker, Dr Shveta Gupta, will discuss the new product’s clinical study, safety, efficacy, and mechanism of action. You’ll also learn about the innovative pen device! A Q&A session will follow the presentation to answer your questions. We hope you will join us!
Dr. Gupta is a board-certified Pediatric Hematologist who specializes in providing care to girls and young women with blood disorders. She joined Alliance Obstetrics & Gynecology Group in 2024. Dr. Gupta previously served as Director of the Hemostasis and Thrombosis Center and as an attending physician for pediatric hematology/oncology at the Arnold Palmer Hospital for Children. Her clinical expertise spans a wide range of hematological conditions, including bleeding and thrombotic disorders, hemoglobinopathies, and red cell membrane and enzyme disorders.
Dr. Gupta attended medical school at the All-India Institute of Medical Sciences in New Delhi. She then completed a residency in pediatrics followed by a fellowship in Hematology/Oncology at the esteemed Children’s Hospital Los Angeles. She further specialized in Transfusion Medicine and Coagulation at Texas Children’s Hospital and Baylor College of Medicine in Houston.
She is a member of various professional organizations, including the Hemostasis and Thrombosis Research Society, International Society on Thrombosis and Haemostasis, and American Society of Pediatric Hematology/Oncology.
